Antiviral immunotropic agent for the treatment of acute respiratory viral infections
The proposed methods of treatment pertain to medicine, in particular pharmacology, and concerns the application of a nasal medicinal composition containing hexapeptide tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine or its pharmaceutically acceptable salt for the treatment of acute respiratory...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
21.06.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The proposed methods of treatment pertain to medicine, in particular pharmacology, and concerns the application of a nasal medicinal composition containing hexapeptide tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine or its pharmaceutically acceptable salt for the treatment of acute respiratory viral infections (ARVIs), in particular those caused by the influenza virus. |
---|---|
Bibliography: | Application Number: US201816221475 |